Logo

• Open gynecological cancer (KGOG2021)

  Three-year Recurrence free survival in patients with ultra-low-risk Endometrial cancer who do not undergo lymph node dissEction (TREE)

  • PI / PI기관 Kidong Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-02-18
  • Current Enrollment / Estimated Enrollment 102 person / 153 person (67.0%)

• Open gynecological cancer (KGOG2020)

  Phase II study of fertility-sparing management using high-dose oral progestin in young women with stage I endometrial adenocarcinoma with grade 2 differentiation or superficial myometrial invasion

  • PI / PI기관 Jeong Yeol Park / Asan Medical Center()
  • Registration Date / Last Update Posted 2022-05-10 / 2025-04-18
  • Current Enrollment / Estimated Enrollment 24 person / 41 person (59.0%)

• Open gynecological cancer (KGOG1047)

  Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr: A phase III, randomized controlled clinical trial (DEBULK trial)

  • PI / PI기관 Ju-Won Roh / CHA Ilsan Medical Center()
  • Registration Date / Last Update Posted 2022-05-10 / 2025-04-18
  • Current Enrollment / Estimated Enrollment 42 person / 240 person (17.5%)

• Open gynecological cancer (KGOG1043)

  ENGOT_Cx12_GOG3037: A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator’s Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer

  • PI / PI기관 Sungjong Lee /
  • Registration Date / Last Update Posted 2022-05-10 / 2022-05-10
  • Current Enrollment / Estimated Enrollment 130 person / 482 person (27.0%)

• Open gynecological cancer (KGOG1038)

  Phase II study of Belotecan monotherapy in patients with recurrent or persistent cervical cancer

  • PI / PI기관 Lee Gwang Beom / Gachon University Gil Medical Center()
  • Registration Date / Last Update Posted 2022-05-10 / 2025-04-18
  • Current Enrollment / Estimated Enrollment 12 person / 21 person (57.1%)

• Open gynecological cancer (KGOG1036)

  A PROBE (Prospective-specimen-collection and retrospective blinded-evaluation) study of HPV viral load to improve cervical cancer screening

  • PI / PI기관 Ju Won Roh /
  • Registration Date / Last Update Posted 2022-05-10 / 2022-05-10
  • Current Enrollment / Estimated Enrollment 435 person / 3000 person (14.499999999999998%)

• Open gynecological cancer (KGOG1032)

  GOG-278: EVALUATION OF PHYSICAL FUNCTION AND QUALITY OF LIFE (QOL) BEFORE AND AFTER NON-RADICAL SURGICAL THERAPY (EXTRA FASCIAL HYSTERECTOMY OR CONE BIOPSY WITH PELVIC LYMPHADENECTOMY) FOR STAGE IA1 (LVSI+) and IA2-IB1 (≤ 2CM) CERVICAL CANCER

  • PI / PI기관 Monn-Hong Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2022-05-10
  • Current Enrollment / Estimated Enrollment 99 person / 220 person (45.0%)

• Open gynecological cancer (KGOG1030)

  Multi-center, Retrospective Study of Developing Risk Assessment Model for Recurrences in Locally Advanced Cervical Cancer Patients Treated with Definitive Concurrent Chemoradiation Therapy

  • PI / PI기관 Dae-Yeon Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-29
  • Current Enrollment / Estimated Enrollment 0 person / 600 person (0.0%)

• Open gynecological cancer (KGOG1008)

  GOG 263: Randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer treated with initial radical hysterectomy and pelvic lymphadenectomy

  • PI / PI기관 Young Tak Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2022-05-10
  • Current Enrollment / Estimated Enrollment 341 person / 360 person (94.69999999999999%)

• Open gynecological cancer (KGOG3051)

  NRG-GY019: A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum

  • PI / PI기관 Kidong Kim / Seoul National University Bundang Hospital()
  • Registration Date / Last Update Posted 2022-05-10 / 2025-04-18
  • Current Enrollment / Estimated Enrollment 431 person / 450 person (95.8%)

* (사)대한부인종양연구회는 게시된 세부 임상연구 정보에 대해 법적 책임이 없습니다.